Bonn University Eye Clinic
Bonn, Germany
- Address
- Ernst-Abbe-Straße 2, 53127 Bonn, Germany
- Aug.Implantat@ukbonn.de
- Phone
- +49 228 287-15505

PRIMA is approved for commercial use in the EU/EEA. In all other regions, PRIMA is being studied for vision restoration in dry age-related macular degeneration and other forms of retinal atrophy, and is not available for commercial distribution. If you or a family member have one of these conditions, we encourage you to join our patient registry to stay informed about clinical research and future availability.
The PRIMA procedure will be exclusively available at these certified centers of excellence.
Find a center near me
10 certified centers
Bonn, Germany

Prof. Frank Holz
Director

Sulzbach, Germany

Prof. Dr. Peter Szurman
Chairman of the Eye Clinic

Ludwigshafen, Germany

Prof. Lars-Olof Hattenbach
Director and Chief Physician, Specialist in Ophthalmology

Hamburg, Germany

Univ.-Prof. Dr. med. Martin Spitzer
Consultant Ophthalmologist

Lübeck, Germany

Prof. Dr. Salvatore Grisanti
Director of Opthamology

London, United Kingdom

Assoc Prof. Mahi Muqit
Specialist in Vitreoretinal Surgery

Munich, Germany

Siegfried G. Priglinger, MD, FEBO
Professor of Ophthalmology, Head and Chair

Münster, Germany

Prof. Dr. med. Nicole Eter
Director of the Clinic

Trier, Germany

Prof. Dr. med. Kai Januschowski
Medical Director

Ulm, Germany

Prof. Dr. med. Armin Wolf
Medical Director


Your central photoreceptors are damaged but the rest of your eye is healthy
Current eligibility requirements exclude patients with conditions affecting other parts of the eye, including glaucoma, cataract, wet macular degeneration, corneal disease, optic neuropathy, vein or artery occlusion, or retinal detachment.
You have low vision in both eyes
The area of atrophy in the eye is large enough to accommodate the implant
| Condition | Status |
|---|---|
| Age-related macular degeneration | Approved in the European Union; It is not approved or available for sale in any other country. In Australia, PRIMA is available only to participants in clinical trials. |
| Stargardt disease | Investigational |
| Retinitis pigmentosa | Investigational |
The PRIMA procedure requires specialized vitreoretinal surgical techniques and post-operative rehabilitation. It is exclusively available at certified centers of excellence.